Clinical Trials Browser

Phase 2 × Recruiting × eltrombopag × Clear all

NCT06630221 2025-07-03

Eltrombopag as a Novel Therapeutic Approach for Low-risk MDS and CMML With TET2 Mutations

Phase 2 Recruiting

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT04600960 2025-02-24

Eltrombopag for Chemotherapy-induced Thrombocytopenia

Phase 2 Recruiting

Classical hematology

Chemotherapy-induced Thrombocytopenia

NCT05961410 2024-10-18

EPBSCH

Phase 2 Recruiting

Lymphoma